APP and Alzheimer disease: An increasing awareness of inadvertent gene dosage, genomic insertion and unspecific promoter effects, combined with concern over unpredictable consequences of the unnatural release of extracellular and intracellular non-Aβ APP fragments that accompany the Aβ release, prompted the refinement of AD modeling strategies.